Keyphrases
Antibiotics
100%
Targeted Delivery
100%
Chlamydial Infection
100%
PLGA Nanoparticles
100%
Chlamydia
42%
Nanoparticles
28%
Azithromycin
28%
Infected Cells
28%
Rifampin
28%
Chronic Disease
14%
Host Cell
14%
Therapeutic Efficacy
14%
Latently Infected
14%
Antibiotic Therapy
14%
Poly(d,l-lactide-co-glycolide)
14%
Chlamydia Trachomatis
14%
Metabolic Rate
14%
Chlamydia Pneumoniae
14%
Persistent Infection
14%
PLA Polymer
14%
Intracellular Bacterial Pathogens
14%
Nanoparticle Enhancement
14%
Inclusion Complex
14%
Cell Cytoplasm
14%
Normal Delivery
14%
Intracellular Trafficking
14%
Chlamydial Inclusion
14%
Microbial Burden
14%
Intracellular Drug Concentration
14%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotics
100%
Nanoparticle
100%
Chlamydiasis
100%
Chlamydiae
42%
Rifampicin
28%
Azithromycin
28%
Infectious Agent
14%
Drug Concentration
14%
Chlamydia Pneumoniae
14%
Antibiotic Therapy
14%
Chronic Disease
14%
Polyglactin
14%
Persistent Infection
14%
Combination Therapy
14%
Chlamydia Trachomatis
14%